Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
May 11, 2022
This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks.
CGD NOTES
April 07, 2022
While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...
Blog Post
April 07, 2022
While oral antivirals are not a substitute for vaccination, they help prevent severe illness, save lives, and preserve health systems. Vaccination rates continue to lag in low-income countries: only 14 percent of the population in low-income countries has received one dose of the vaccine, compared t...
Mar
23
2022
11:00—12:15 PM Eastern Time (US & Canada)
March 15, 2022
Well-functioning supply chains to deliver medicines, vaccines, and other health products are the backbone of the health system. Continued challenges in the financing, procurement, and distribution of health products lead to frequent stockouts at health clinics, putting treatment programs at risk and...
WORKING PAPERS
January 28, 2022
Providing patients with high-quality essential medicines requires a well-functioning procurement, distribution, and regulatory system. However, in many low- and lower-middle-income countries (LMICs), public sector supply chain performance is far from optimal, resulting in frequent stockouts at healt...
Nov
30
2021
9:00—10:15 AM Eastern Time (US and Canada)
November 17, 2021
Ineffective and inefficient registration processes impede access to lifesaving, quality-assured essential medicines. As a result of inadequate legal provisions, limited capacity within National Regulatory Authorities, and long and unpredictable registration processes as well as low profit margins an...
CGD NOTES
August 11, 2021
Over the past two decades, partnerships between bilateral and multilateral funders, philanthropy, national governments, and the private sector have substantially increased global access to effective malaria treatment. Nevertheless, further action on malaria case management is needed to meet global t...
WORKING PAPERS
December 14, 2020
Between 2011 and 2016, the Affordable Medicines Facility-Malaria (AMFm) subsidy program substantially increased access to WHO prequalified artemisinin combination therapies (ACTs) through Africa’s private sector pharmacies and drug-sellers. While the program was rigorously and extensively evaluated,...
CGD NOTES
May 05, 2020
Much of the policy debate regarding COVID-19 medical equipment focuses on the question of which form of patient respiratory support is effective in low-resources settings. However, irrespective of the specific form of respiratory support used, the long-term and cost-effective functioning of all form...
Feb
10
2020
10:00—11:30 AM
January 31, 2020
Spending on pharmaceuticals and other health care commodities is one of the fastest growing elements of healthcare spending in rich and poorer countries alike. A popular response to the problem of escalating drugs budgets has been seeking transparency of drug pricing within and across borders. In a ...